Long-term use of sorafenib (SOR) in metastatic renal cell carcinoma (mRCC) previously treated with systemic therapy

Michele Battaglia,A. Gernone

Long-term use of sorafenib (SOR) in metastatic renal cell carcinoma (mRCC) previously treated with systemic therapy

2009

Michele Battaglia
A. Gernone

e16123 Background: The recent development of new targeted agents for the treatment of advanced RCC has definitely changed the approach and the outcome of this disease. Among them, SOR, has proved t...

Keywords:

Renal cell carcinoma
Internal medicine
Sorafenib
Oncology
Cancer research
Systemic therapy
Medicine
Disease
previously treated

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations